HSCS
HSCS
NASDAQ · Health Care

Heartsciences Inc

$2.25
-0.06 (-2.60%)
Financial Highlights (FY 2026)
Revenue
14.3K
Net Income
-28,998,261
Gross Margin
56.8%
Profit Margin
-201,499.5%
Rev Growth
-32.9%
D/E Ratio
12.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.8% 56.8% 46.4% 46.4%
Operating Margin -192,013.1% -172,817.4% 16.1% 16.8%
Profit Margin -201,499.5% -191,424.6% 17.0% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.3K 21.3K 3.30M 3.40M
Gross Profit 8.1K 12.1K 1.53M 1.58M
Operating Income -27,415,630 -36,772,081 530.1K 570.8K
Net Income -28,998,261 -38,894,835 560.2K 453.4K
Gross Margin 56.8% 56.8% 46.4% 46.4%
Operating Margin -192,013.1% -172,817.4% 16.1% 16.8%
Profit Margin -201,499.5% -191,424.6% 17.0% 13.3%
Rev Growth -32.9% -32.9% +13.2% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.40M 3.40M 3.60M 4.54M
Total Equity 273.8K 273.8K 4.32M 3.69M
D/E Ratio 12.43 12.43 0.83 1.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,218,385 -38,535,716 944.9K 908.1K
Free Cash Flow 381.1K 454.7K